These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12191692)

  • 1. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
    Shin SC; Lee HJ
    Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer.
    Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC
    Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
    Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
    Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of TPX polymer membranes for the controlled release of triprolidine.
    Shin SC; Yoon MK
    Int J Pharm; 2002 Jan; 232(1-2):131-7. PubMed ID: 11790496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of pranoprofen from the ethylene-vinyl acetate matrix using plasticizer.
    Cho CW; Choi JS; Shin SC
    Drug Dev Ind Pharm; 2007 Jul; 33(7):747-53. PubMed ID: 17654023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix.
    Shin SC; Lee HJ
    Eur J Pharm Biopharm; 2002 Nov; 54(3):325-8. PubMed ID: 12445563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate.
    Tallury P; Alimohammadi N; Kalachandra S
    Dent Mater; 2007 Apr; 23(4):404-9. PubMed ID: 16556460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihistamine effects of triprolidine from the transdermal administration of the TPX matrix in rats.
    Shin SC; Choi JS
    Arch Pharm Res; 2005 Jan; 28(1):111-4. PubMed ID: 15742818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Controlled Transdermal Delivery of Mexazolam Using Ethylene-vinyl Acetate.
    Weon Cho C; Chul Shin S
    Iran J Pharm Res; 2012; 11(1):3-12. PubMed ID: 25317180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained release from hot-melt extruded matrices based on ethylene vinyl acetate and polyethylene oxide.
    Almeida A; Brabant L; Siepmann F; De Beer T; Bouquet W; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2012 Nov; 82(3):526-33. PubMed ID: 22986082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of limonene-based membrane-moderated transdermal therapeutic system of nimodipine.
    Krishnaiah YS; Bhaskar P; Satyanarayana V
    Drug Deliv; 2004; 11(1):1-9. PubMed ID: 15168785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release.
    Tang M; Hou J; Lei L; Liu X; Guo S; Wang Z; Chen K
    Int J Pharm; 2010 Nov; 400(1-2):66-73. PubMed ID: 20804834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal delivery of triprolidine using TPX polymer membrane.
    Shin SC; Kim J; Yoon MK; Oh IJ; Choi JS
    Int J Pharm; 2002 Mar; 235(1-2):141-7. PubMed ID: 11879749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a membrane-controlled transdermal therapeutic system containing isosorbide dinitrate.
    Ocak F; Ağabeyoğlu I
    Int J Pharm; 1999 Apr; 180(2):177-83. PubMed ID: 10370188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of ethylene vinyl acetate copolymers (EVA) in drug delivery systems.
    Schneider C; Langer R; Loveday D; Hair D
    J Control Release; 2017 Sep; 262():284-295. PubMed ID: 28789964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced transdermal absorption and pharmacokinetic evaluation of pranoprofen-ethylene-vinyl acetate matrix containing penetration enhancer in rats.
    Cho CW; Choi JS; Yang KH; Shin SC
    Arch Pharm Res; 2009 May; 32(5):747-53. PubMed ID: 19471890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.